BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
McKinsey
Express Scripts
Julphar
Healthtrust
Cipla
Farmers Insurance
Colorcon
Baxter

Generated: January 16, 2018

DrugPatentWatch Database Preview

CARBOPLATIN - Generic Drug Details

« Back to Dashboard

What are the generic sources for carboplatin and what is the scope of carboplatin patent protection?

Carboplatin
is the generic ingredient in two branded drugs marketed by Cipla Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pliva, Sandoz, Watson Labs Teva, West-ward Pharms Int, Corden Pharma, Accord Hlthcare, Actavis Totowa, Akorn, Fresenius Kabi Oncol, Gland Pharma Ltd, Ingenus Pharms Llc, Mylan Institutional, Nanjing King-friend, Pharmachemie Bv, Pliva Lachema, Sandoz Inc, Sanja Pharms Co, Sun Pharma Global, Teva Parenteral, Teva Pharms Usa, and Cordenpharma, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carboplatin. Twelve suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for CARBOPLATIN
Medical Subject Heading (MeSH) Categories for CARBOPLATIN
Tentative approvals for CARBOPLATIN
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe50MG/VIALINJECTABLE;INJECTION
➤ Subscribe➤ Subscribe450MG/VIALINJECTABLE;INJECTION
➤ Subscribe➤ Subscribe150MG/VIALINJECTABLE;INJECTION

US Patents and Regulatory Information for CARBOPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva Lachema CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 078631-003 Dec 2, 2008 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ingenus Pharms Llc CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 208487-001 Apr 26, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077998-002 Apr 24, 2007 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CARBOPLATIN carboplatin INJECTABLE;INJECTION 076473-001 Oct 27, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz CARBOPLATIN carboplatin INJECTABLE;INJECTION 076959-001 Mar 18, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nanjing King-friend CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077096-001 Jun 14, 2005 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077266-003 Feb 15, 2006 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nanjing King-friend CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077096-003 Jun 14, 2005 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmachemie Bv CARBOPLATIN carboplatin INJECTABLE;IV (INFUSION) 077269-002 Oct 14, 2004 AP RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CARBOPLATIN carboplatin INJECTABLE;INJECTION 076473-003 Oct 27, 2004 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CARBOPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-002 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-001 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-002 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-003 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-001 Jul 14, 2003 ➤ Subscribe ➤ Subscribe
Corden Pharma PARAPLATIN carboplatin INJECTABLE;INJECTION 019880-003 Mar 3, 1989 ➤ Subscribe ➤ Subscribe
Cordenpharma PARAPLATIN carboplatin INJECTABLE;IV (INFUSION) 020452-004 Jan 15, 2004 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Cantor Fitzgerald
Daiichi Sankyo
US Department of Justice
Novartis
Deloitte
Queensland Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot